Meteorin Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration
Abstract
:1. Introduction
2. Material and Method
2.1. Ethics for Animal Use
2.2. Regulation of MTRN Expression in Rat Retina by Aldosterone and/or Spironolactone, Which Regulate the Mineralocorticoid Pathway
2.3. Immunohistochemistry on Rat Retina
2.4. Immunohistochemistry on Non-Human Primate and Human Samples
2.5. Laser-Induced CNV Rat Model
2.6. Treatments
2.7. Fluorescein Angiography (FA)
2.8. RPE/Choroid Flat-Mounts and CNV Quantifications
2.9. Statistics
2.10. RNA-Sequencing Data Analysis
3. Results
3.1. MTRN Is Widely Distributed in the Rat Neural Retina and in the Retinal Pigment Epithelium and Its Expression Is Regulated by Mineralocorticoid Pathway
3.2. MTRN Is Concentrated in the Macula and Co-Localized with Thrombospondin in Non-Human Primate
3.3. MTRN Is Distributed in All Retinal Layers of the Human Neural Retina
3.4. MTRN Is Secreted and Sequestered in PML Nuclear Bodies
3.5. MTRN Reduces Laser-Induced Choroidal Neovascularization Both in a Preventive and Curative Regimen
3.6. MTRN Regulates Genes and Pathways Involved in Angiogenesis Independent from VEGF in the RPE/Choroid and in the Retina
4. Discussion
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Data Availability Statement
Conflicts of Interest
References
- Wong, W.L.; Su, X.; Li, X.; Cheung, C.M.G.; Klein, R.; Cheng, C.-Y.; Wong, T.Y. Global Prevalence of Age-Related Macular Degeneration and Disease Burden Projection for 2020 and 2040: A Systematic Review and Meta-Analysis. Lancet Glob. Health 2014, 2, e106–e116. [Google Scholar] [CrossRef] [Green Version]
- Rosenfeld, P.J.; Brown, D.M.; Heier, J.S.; Boyer, D.S.; Kaiser, P.K.; Chung, C.Y.; Kim, R.Y.; MARINA Study Group. Ranibizumab for Neovascular Age-Related Macular Degeneration. N. Engl. J. Med. 2006, 355, 1419–1431. [Google Scholar] [CrossRef] [Green Version]
- Chang, T.S.; Bressler, N.M.; Fine, J.T.; Dolan, C.M.; Ward, J.; Klesert, T.R.; MARINA Study Group. Improved Vision-Related Function after Ranibizumab Treatment of Neovascular Age-Related Macular Degeneration: Results of a Randomized Clinical Trial. Arch. Ophthalmol. 2007, 125, 1460–1469. [Google Scholar] [CrossRef] [PubMed]
- Martin, D.F.; Maguire, M.G.; Ying, G.; Grunwald, J.E.; Fine, S.L.; Jaffe, G.J.; CATT Research Group. Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration. N. Engl. J. Med. 2011, 364, 1897–1908. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rezar-Dreindl, S.; Sacu, S.; Eibenberger, K.; Pollreisz, A.; Bühl, W.; Georgopoulos, M.; Krall, C.; Weigert, G.; Schmidt-Erfurth, U. The Intraocular Cytokine Profile and Therapeutic Response in Persistent Neovascular Age-Related Macular Degeneration. Investig. Ophthalmol. Vis. Sci. 2016, 57, 4144–4150. [Google Scholar] [CrossRef] [Green Version]
- Behar-Cohen, F. Towards an Optimized Use of Ocular Corticosteroids: EURETINA Award Lecture 2017. Ophthalmologica 2018, 240, 111–119. [Google Scholar] [CrossRef] [PubMed]
- Gillies, M.C.; Simpson, J.M.; Luo, W.; Penfold, P.; Hunyor, A.B.L.; Chua, W.; Mitchell, P.; Billson, F. A Randomized Clinical Trial of a Single Dose of Intravitreal Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration: One-Year Results. Arch. Ophthalmol. 2003, 121, 667–673. [Google Scholar] [CrossRef]
- Zhao, M.; Valamanesh, F.; Celerier, I.; Savoldelli, M.; Jonet, L.; Jeanny, J.-C.; Jaisser, F.; Farman, N.; Behar-Cohen, F. The Neuroretina Is a Novel Mineralocorticoid Target: Aldosterone up-Regulates Ion and Water Channels in Müller Glial Cells. FASEB J. 2010, 24, 3405–3415. [Google Scholar] [CrossRef]
- Zhao, M.; Célérier, I.; Bousquet, E.; Jeanny, J.-C.; Jonet, L.; Savoldelli, M.; Offret, O.; Curan, A.; Farman, N.; Jaisser, F.; et al. Mineralocorticoid Receptor Is Involved in Rat and Human Ocular Chorioretinopathy. J. Clin. Investig. 2012, 122, 2672–2679. [Google Scholar] [CrossRef]
- Allingham, M.J.; Tserentsoodol, N.; Saloupis, P.; Mettu, P.S.; Cousins, S.W. Aldosterone Exposure Causes Increased Retinal Edema and Severe Retinopathy Following Laser-Induced Retinal Vein Occlusion in Mice. Investig. Ophthalmol. Vis. Sci. 2018, 59, 3355–3365. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Canonica, J.; Mehanna, C.; Bonnard, B.; Jonet, L.; Gelize, E.; Jais, J.-P.; Jaisser, F.; Zhao, M.; Behar-Cohen, F. Effect of Acute and Chronic Aldosterone Exposure on the Retinal Pigment Epithelium-Choroid Complex in Rodents. Exp. Eye Res. 2019, 187, 107747. [Google Scholar] [CrossRef]
- Wilkinson-Berka, J.L.; Tan, G.; Jaworski, K.; Miller, A.G. Identification of a Retinal Aldosterone System and the Protective Effects of Mineralocorticoid Receptor Antagonism on Retinal Vascular Pathology. Circ. Res. 2009, 104, 124–133. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zhao, M.; Mantel, I.; Gelize, E.; Li, X.; Xie, X.; Arboleda, A.; Seminel, M.; Levy-Boukris, R.; Dernigoghossian, M.; Prunotto, A.; et al. Mineralocorticoid Receptor Antagonism Limits Experimental Choroidal Neovascularization and Structural Changes Associated with Neovascular Age-Related Macular Degeneration. Nat. Commun. 2019, 10, 1–13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nishino, J.; Yamashita, K.; Hashiguchi, H.; Fujii, H.; Shimazaki, T.; Hamada, H. Meteorin: A Secreted Protein That Regulates Glial Cell Differentiation and Promotes Axonal Extension. EMBO J. 2004, 23, 1998–2008. [Google Scholar] [CrossRef] [Green Version]
- Lee, H.S.; Han, J.; Lee, S.-H.; Park, J.A.; Kim, K.-W. Meteorin Promotes the Formation of GFAP-Positive Glia via Activation of the Jak-STAT3 Pathway. J. Cell. Sci. 2010, 123, 1959–1968. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wright, J.L.; Ermine, C.M.; Jørgensen, J.R.; Parish, C.L.; Thompson, L.H. Over-Expression of Meteorin Drives Gliogenesis Following Striatal Injury. Front. Cell. Neurosci. 2016, 10, 177. [Google Scholar] [CrossRef] [Green Version]
- Tornøe, J.; Torp, M.; Jørgensen, J.R.; Emerich, D.F.; Thanos, C.; Bintz, B.; Fjord-Larsen, L.; Wahlberg, L.U. Encapsulated Cell-Based Biodelivery of Meteorin Is Neuroprotective in the Quinolinic Acid Rat Model of Neurodegenerative Disease. Restor. Neurol. Neurosci. 2012, 30, 225–236. [Google Scholar] [CrossRef]
- Xie, J.Y.; Qu, C.; Munro, G.; Petersen, K.A.; Porreca, F. Antihyperalgesic Effects of Meteorin in the Rat Chronic Constriction Injury Model: A Replication Study. Pain 2019, 160, 1847–1855. [Google Scholar] [CrossRef]
- Jørgensen, J.R.; Xu, X.-J.; Arnold, H.M.; Munro, G.; Hao, J.-X.; Pepinsky, B.; Huang, C.; Gong, B.J.; Wiesenfeld-Hallin, Z.; Wahlberg, L.U.; et al. Meteorin Reverses Hypersensitivity in Rat Models of Neuropathic Pain. Exp. Neurol. 2012, 237, 260–266. [Google Scholar] [CrossRef]
- Park, J.A.; Lee, H.S.; Ko, K.J.; Park, S.Y.; Kim, J.H.; Choe, G.; Kweon, H.-S.; Song, H.S.; Ahn, J.-C.; Yu, Y.S.; et al. Meteorin Regulates Angiogenesis at the Gliovascular Interface. Glia 2008, 56, 247–258. [Google Scholar] [CrossRef] [PubMed]
- Dobin, A.; Davis, C.A.; Schlesinger, F.; Drenkow, J.; Zaleski, C.; Jha, S.; Batut, P.; Chaisson, M.; Gingeras, T.R. STAR: Ultrafast Universal RNA-Seq Aligner. Bioinformatics 2013, 29, 15–21. [Google Scholar] [CrossRef]
- Li, B.; Dewey, C.N. RSEM: Accurate Transcript Quantification from RNA-Seq Data with or without a Reference Genome. BMC Bioinform. 2011, 12, 323. [Google Scholar] [CrossRef] [Green Version]
- Robinson, M.D.; McCarthy, D.J.; Smyth, G.K. EdgeR: A Bioconductor Package for Differential Expression Analysis of Digital Gene Expression Data. Bioinformatics 2010, 26, 139–140. [Google Scholar] [CrossRef] [Green Version]
- Sahin, U.; de Thé, H.; Lallemand-Breitenbach, V. PML Nuclear Bodies: Assembly and Oxidative Stress-Sensitive Sumoylation. Nucleus 2014, 5, 499–507. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zhao, M.; Rodríguez-Villagra, E.; Kowalczuk, L.; Le Normand, M.; Berdugo, M.; Levy-Boukris, R.; El Zaoui, I.; Kaufmann, B.; Gurny, R.; Bravo-Osuna, I.; et al. Tolerance of High and Low Amounts of PLGA Microspheres Loaded with Mineralocorticoid Receptor Antagonist in Retinal Target Site. J. Control Release 2017, 266, 187–197. [Google Scholar] [CrossRef] [PubMed]
- Delaunay, K.; Khamsy, L.; Kowalczuk, L.; Moulin, A.; Nicolas, M.; Zografos, L.; Lassiaz, P.; Behar-Cohen, F. Glial Cells of the Human Fovea. Mol. Vis. 2020, 26, 235–245. [Google Scholar]
- Yafai, Y.; Eichler, W.; Iandiev, I.; Unterlauft, J.-D.; Jochmann, C.; Wiedemann, P.; Bringmann, A. Thrombospondin-1 Is Produced by Retinal Glial Cells and Inhibits the Growth of Vascular Endothelial Cells. Ophthalmic Res. 2014, 52, 81–88. [Google Scholar] [CrossRef] [PubMed]
- Celen, A.B.; Sahin, U. Sumoylation on Its 25th Anniversary: Mechanisms, Pathology, and Emerging Concepts. FEBS J. 2020, 287, 3110–3140. [Google Scholar] [CrossRef]
- Hsu, K.-S.; Kao, H.-Y. PML: Regulation and Multifaceted Function beyond Tumor Suppression. Cell Biosci. 2018, 8, 1–21. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Palibrk, V.; Suganthan, R.; Scheffler, K.; Wang, W.; Bjørås, M.; Bøe, S.O. PML Regulates Neuroprotective Innate Immunity and Neuroblast Commitment in a Hypoxic-Ischemic Encephalopathy Model. Cell Death Dis. 2016, 7, e2320. [Google Scholar] [CrossRef]
- Chin-Yee, D.; Eck, T.; Fowler, S.; Hardi, A.; Apte, R.S. A Systematic Review of as Needed versus Treat and Extend Ranibizumab or Bevacizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration. Br. J. Ophthalmol. 2016, 100, 914–917. [Google Scholar] [CrossRef] [PubMed]
- Uno, K.; Bhutto, I.A.; McLeod, D.S.; Merges, C.; Lutty, G.A. Impaired Expression of Thrombospondin-1 in Eyes with Age Related Macular Degeneration. Br. J. Ophthalmol. 2006, 90, 48–54. [Google Scholar] [CrossRef] [Green Version]
- Jørgensen, J.R.; Thompson, L.; Fjord-Larsen, L.; Krabbe, C.; Torp, M.; Kalkkinen, N.; Hansen, C.; Wahlberg, L. Characterization of Meteorin--an Evolutionary Conserved Neurotrophic Factor. J. Mol. Neurosci. 2009, 39, 104–116. [Google Scholar] [CrossRef] [PubMed]
- Yuan, X.; Gu, X.; Crabb, J.S.; Yue, X.; Shadrach, K.; Hollyfield, J.G.; Crabb, J.W. Quantitative Proteomics: Comparison of the Macular Bruch Membrane/Choroid Complex from Age-Related Macular Degeneration and Normal Eyes. Mol. Cell. Proteom. 2010, 9, 1031–1046. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Du, S.; Wang, S.; Wu, Q.; Hu, J.; Li, T. Decorin Inhibits Angiogenic Potential of Choroid-Retinal Endothelial Cells by Downregulating Hypoxia-Induced Met, Rac1, HIF-1α and VEGF Expression in Cocultured Retinal Pigment Epithelial Cells. Exp. Eye Res. 2013, 116, 151–160. [Google Scholar] [CrossRef]
- Guo, L.; Hussain, A.A.; Limb, G.A.; Marshall, J. Age-Dependent Variation in Metalloproteinase Activity of Isolated Human Bruch’s Membrane and Choroid. Investig. Ophthalmol. Vis. Sci. 1999, 40, 2676–2682. [Google Scholar]
- Alge-Priglinger, C.S.; Kreutzer, T.; Obholzer, K.; Wolf, A.; Mempel, M.; Kernt, M.; Kampik, A.; Priglinger, S.G. Oxidative Stress-Mediated Induction of MMP-1 and MMP-3 in Human RPE Cells. Investig. Ophthalmol. Vis. Sci. 2009, 50, 5495–5503. [Google Scholar] [CrossRef] [Green Version]
- Zeng, S.; Whitmore, S.S.; Sohn, E.H.; Riker, M.J.; Wiley, L.A.; Scheetz, T.E.; Stone, E.M.; Tucker, B.A.; Mullins, R.F. Molecular Response of Chorioretinal Endothelial Cells to Complement Injury: Implications for Macular Degeneration. J. Pathol. 2016, 238, 446–456. [Google Scholar] [CrossRef] [Green Version]
Antibodies | Species | Reference | Lab provider | Dilution |
---|---|---|---|---|
Anti GFAP Antibody, Cy3 Conjugate | Mouse | MAB3402C3 | Dako cytomation | 1/200 |
Anti Meteorin | Rabbit | Ab12956 | Abcam | 1/100 |
Anti Glutamine synthetase clone GS-6 | Mouse | MAB 302 | Merck Millipore | 1/300 |
Anti TSP1 | Mouse | MA5-13398 | Invitrogen | 1/100 |
SUMO1 | Mouse | Sc5308 | Santa Cruz | 1/100 |
PML | Mouse | PG-M3 sc-966 | Santa Cruz | 1/100 |
AlexaFluo® 488 – AlexaFluo®594 – AlexaFluo®647 | Ab12956 | Invitrogen/Thermofischer | 1/300 | |
4′, 6′ –diamino-2-phenylindo DAPI | Sigma-Aldrich | 1/5000 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Delaunay, K.; Sellam, A.; Dinet, V.; Moulin, A.; Zhao, M.; Gelizé, E.; Canonica, J.; Naud, M.-C.; Crisanti-Lassiaz, P.; Behar-Cohen, F. Meteorin Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration. J. Clin. Med. 2021, 10, 2973. https://doi.org/10.3390/jcm10132973
Delaunay K, Sellam A, Dinet V, Moulin A, Zhao M, Gelizé E, Canonica J, Naud M-C, Crisanti-Lassiaz P, Behar-Cohen F. Meteorin Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration. Journal of Clinical Medicine. 2021; 10(13):2973. https://doi.org/10.3390/jcm10132973
Chicago/Turabian StyleDelaunay, Kimberley, Alexandre Sellam, Virginie Dinet, Alexandre Moulin, Min Zhao, Emmanuelle Gelizé, Jérémie Canonica, Marie-Christine Naud, Patricia Crisanti-Lassiaz, and Francine Behar-Cohen. 2021. "Meteorin Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration" Journal of Clinical Medicine 10, no. 13: 2973. https://doi.org/10.3390/jcm10132973
APA StyleDelaunay, K., Sellam, A., Dinet, V., Moulin, A., Zhao, M., Gelizé, E., Canonica, J., Naud, M. -C., Crisanti-Lassiaz, P., & Behar-Cohen, F. (2021). Meteorin Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration. Journal of Clinical Medicine, 10(13), 2973. https://doi.org/10.3390/jcm10132973